文献速递其他结缔组织病

LIPS法提升肌炎特异性自身抗体检测准确性:与线性印迹和免疫沉淀法的比较

Improved Detection of Myositis-Specific Autoantibodies Using Luciferase Immunoprecipitation Systems Assay: Comparison With Line Blot and Conventional Immunoprecipitation.
PubMed 文献 · Arthritis Rheumatol · 2026-03-31

该研究分析了279份血清,比较LIPS法与线性印迹和免疫沉淀(IP)检测肌炎特异性自身抗体的性能。LIPS与IP高度一致(κ=0.90,AUC=0.935),优于线性印迹,尤其在低至中等滴度时减少误分类,有望改善肌炎患者临床分层。

要点

  • LIPS与IP高度一致(κ=0.90,AUC=0.935),性能优于线性印迹。
  • 线性印迹阈值≥36 AU敏感性92.9%但特异性73.8%,≥71 AU特异性92.9%但敏感性82.8%。
  • 抗体特异性阈值可改善一致性,但定量性能仍逊于LIPS。

核心结论

  • LIPS提供定量区分,与IP强一致,性能优于线性印迹,尤其在低至中等滴度时。
  • LIPS通过减少误分类并补充抗体特异性阈值,有潜力增强肌炎患者的临床分层。

研究设计与样本

  • 研究分析了279份来自Johns Hopkins肌炎中心的血清,均具有线性印迹结果。
  • 对anti-Jo-1、anti-PL-7、anti-PL-12、anti-MDA-5、anti-EJ和anti-Ro52自身抗体进行LIPS检测。
  • 线性印迹结果使用标准阈值(≥36 AU和≥71 AU)评估,并以IP(n=141)为参照评估检测性能。
  • 在无IP的患者(n=138)中,检查了临床诊断。

主要发现

  • LIPS与IP显示极好一致性(κ=0.90,AUC=0.935),优于线性印迹。
  • 线性印迹阈值≥36 AU敏感性92.9%、特异性73.8%;≥71 AU特异性92.9%、敏感性82.8%。
  • 在无IP的患者中,LIPS与线性印迹的一致性在≥36 AU时为89%,在≥71 AU时为83%。
  • LIPS阳性病例富集于抗合成酶综合征和皮肌炎。
  • 在不一致病例中(线性印迹阳性而LIPS阴性),多数临床分类为包涵体肌炎(11例中5例)。

关键数值与推荐

  • 线性印迹标准阈值:≥36 AU和≥71 AU。
  • LIPS与IP一致性:κ=0.90,AUC=0.935。
  • 线性印迹≥36 AU:敏感性92.9%,特异性73.8%。
  • 线性印迹≥71 AU:特异性92.9%,敏感性82.8%。

临床怎么用

  • LIPS可作为肌炎特异性自身抗体的定量检测方法,尤其在线性印迹低至中等滴度时减少误分类。
  • 临床解读线性印迹结果时需注意阈值影响敏感性及特异性,抗体特异性阈值可改善一致性但不及LIPS。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Myositis-specific autoantibodies guide the diagnosis and classification of idiopathic inflammatory myopathies, but current immunoassays vary in accuracy, particularly for autoantibodies associated with interstitial lung disease. To compare the performance of the luciferase immunoprecipitation systems (LIPS) assay with line blot and immunoprecipitation (IP) and to evaluate whether antibody-specific thresholds modify line blot concordance. METHODS: We analyzed 279 sera with line blot results from the Johns Hopkins Myositis Center. LIPS was performed for anti-Jo-1, anti-PL-7, anti-PL-12, anti-MDA-5, anti-EJ, and anti-Ro52 autoantibodies. Line blot results were evaluated using standard thresholds (≥36 and ≥71 arbitrary units [AU]). Assay performance was evaluated against IP (n = 141). In patients without IP (n = 138), clinical diagnoses were examined. RESULTS: LIPS showed excellent agreement with IP (κ = 0.90, area under the receiver operating characteristic curve 0.935), outperforming line blot. Line blot cutoffs influenced performance: ≥36 AU increased sensitivity (92.9%) but reduced specificity (73.8%), whereas ≥71 AU improved specificity (92.9%) but lowered sensitivity (82.8%). Antibody-specific thresholds modified concordance but remained quantitatively inferior to LIPS. In patients without IP, concordance between LIPS and line blot was 89% at ≥36 AU and 83% at ≥71 AU. LIPS-positive cases were enriched for antisynthetase syndrome and dermatomyositis. Among discordant cases (line blot positive and LIPS negative), most were clinically classified as inclusion body myositis (5 of 11). For anti-Ro52, discrepancies were most frequent at titers <36 AU. CONCLUSION: LIPS provides quantitative discrimination, strong concordance with IP, and improved performance compared with line blot, particularly at low to intermediate titers. By reducing misclassification and complementing antibody-specific thresholds, LIPS has the potential to enhance clinical stratification in patients with myositis.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Burbelo PD, Pinal-Fernandez I, Casal-Dominguez M, et al. Improved Detection of Myositis-Specific Autoantibodies Using Luciferase Immunoprecipitation Systems Assay: Comparison With Line Blot and Conventional Immunoprecipitation. Arthritis Rheumatol. 2026. PMID: 41728979. doi:10.1002/art.70103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。